Finomel Peri Emulsion for Infusion Ireland - English - HPRA (Health Products Regulatory Authority)

finomel peri emulsion for infusion

baxter holding b.v. - alanine; arginine ; glycine; histidine; isoleucine; leucine ; lysine hydrochloride; methionine; phenylalanine; proline; serine; threonine; tryptophan; tyrosine; valine; sodium acetate trihydrate ; potassium chloride; calcium chloride dihydrate; magnesium sulphate heptahydrate ; sodium glycerophosphate hydrate; zinc sulphate heptahydrate; glucose monohydrate; soya bean oil, refined ph.eur; olive oil, refined; medium chain triglycerides saturated; fish oil, rich in omega-3 acids - emulsion for infusion - 13 %+ 10 % +20 percent - solutions for parenteral nutrition; amino acids

GLUCOSE 50 % Israel - English - Ministry of Health

glucose 50 %

lapidot medical import and marketing ltd - glucose as monohydrate - concentrate for solution for infusion - glucose as monohydrate 50 % - glucose - glucose - high caloric carbohydrate infusion hypoglycaemia.

Glucose Injection (Baxter) New Zealand - English - Medsafe (Medicines Safety Authority)

glucose injection (baxter)

baxter healthcare ltd - glucose monohydrate 10% - solution for infusion - 10 % - active: glucose monohydrate 10% - hypertonic infusion solutions are indicated: - as a source of energy incorporated with parenteral nutrition with minimal dilution effect - for use with an appropriate protein (nitrogen) source in the prevention of nitrogen loss or in the treatment of negative nitrogen balance in patients where: a) the alimentary tract cannot or should not be used b) gastrointestinal absorption of protein is impaired c) metabolic requirements for protein are substantially increased, as with extensive burns.

Glucose Injection (Baxter) New Zealand - English - Medsafe (Medicines Safety Authority)

glucose injection (baxter)

baxter healthcare ltd - glucose monohydrate 25% - solution for infusion - 25 % - active: glucose monohydrate 25% - hypertonic infusion solutions are indicated: - as a source of energy incorporated with parenteral nutrition with minimal dilution effect - for use with an appropriate protein (nitrogen) source in the prevention of nitrogen loss or in the treatment of negative nitrogen balance in patients where: a) the alimentary tract cannot or should not be used b) gastrointestinal absorption of protein is impaired c) metabolic requirements for protein are substantially increased, as with extensive burns.

Glucose Injection (Baxter) New Zealand - English - Medsafe (Medicines Safety Authority)

glucose injection (baxter)

baxter healthcare ltd - glucose monohydrate 50% - solution for infusion - 50 % - active: glucose monohydrate 50% - hypertonic infusion solutions are indicated: - as a source of energy incorporated with parenteral nutrition with minimal dilution effect - for use with an appropriate protein (nitrogen) source in the prevention of nitrogen loss or in the treatment of negative nitrogen balance in patients where: a) the alimentary tract cannot or should not be used b) gastrointestinal absorption of protein is impaired c) metabolic requirements for protein are substantially increased, as with extensive burns.

Glucose Injection (Baxter) New Zealand - English - Medsafe (Medicines Safety Authority)

glucose injection (baxter)

baxter healthcare ltd - glucose monohydrate 70% - solution for infusion - 70 % - active: glucose monohydrate 70% - hypertonic infusion solutions are indicated: - as a source of energy incorporated with parenteral nutrition with minimal dilution effect - for use with an appropriate protein (nitrogen) source in the prevention of nitrogen loss or in the treatment of negative nitrogen balance in patients where: a) the alimentary tract cannot or should not be used b) gastrointestinal absorption of protein is impaired c) metabolic requirements for protein are substantially increased, as with extensive burns.

GLUCOSE 10 % Israel - English - Ministry of Health

glucose 10 %

lapidot medical import and marketing ltd - glucose as monohydrate - solution for infusion - glucose as monohydrate 10 % - glucose - glucose - carbohydrate infusion therapy : - hypoglycaemic situations, - hypertonic dehydration , - hypertonic electrolyte disturbances. vehicle solution for supplementary medication.

GLUCOSE Ireland - English - HPRA (Health Products Regulatory Authority)

glucose

baxter healthcare limited - glucose monohydrate - solution for infusion - 10 %w/v - carbohydrates

GLUCOSE Ireland - English - HPRA (Health Products Regulatory Authority)

glucose

maco pharma (uk) ltd - glucose monohydrate - solution for infusion - 5 %w/v - electrolytes with carbohydrates

GLUCOSE 5% W/V INTRAVENOUS INFUSION Ireland - English - HPRA (Health Products Regulatory Authority)

glucose 5% w/v intravenous infusion

baxter healthcare limited - glucose monohydrate - solution for infusion - 5.0 anhyd %w/v - carbohydrates